These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8895754)
1. Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway. Luo W; Sharif TR; Sharif M Cancer Res; 1996 Nov; 56(21):4983-91. PubMed ID: 8895754 [TBL] [Abstract][Full Text] [Related]
2. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells. Luo W; Sharif TR; Houghton PJ; Sharif M Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245 [TBL] [Abstract][Full Text] [Related]
3. Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway. Sharif TR; Luo W; Sharif M Mol Cell Endocrinol; 1997 Jun; 130(1-2):119-30. PubMed ID: 9220028 [TBL] [Abstract][Full Text] [Related]
4. Substance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cells. Gallicchio M; Rosa AC; Benetti E; Collino M; Dianzani C; Fantozzi R Br J Pharmacol; 2006 Mar; 147(6):681-9. PubMed ID: 16432508 [TBL] [Abstract][Full Text] [Related]
5. Substance P (NK(1)) receptor expression by human colonic epithelial cell line Caco-2. Böckmann S Peptides; 2002 Oct; 23(10):1783-91. PubMed ID: 12383866 [TBL] [Abstract][Full Text] [Related]
6. Rapamycin inhibits substance P-induced protein synthesis and phosphorylation of PHAS-I (4E-BP1) and p70 S6 kinase (p70(S6K)) in human astrocytoma cells. Sharif M; Sharif T; Dilling M; Hosoi H; Lawrence J; Houghton P Int J Oncol; 1997 Oct; 11(4):797-805. PubMed ID: 21528277 [TBL] [Abstract][Full Text] [Related]
7. Ketamine suppresses the substance P-induced production of IL-6 and IL-8 by human U373MG glioblastoma/astrocytoma cells. Yamaguchi K; Kumakura S; Murakami T; Someya A; Inada E; Nagaoka I Int J Mol Med; 2017 Mar; 39(3):687-692. PubMed ID: 28204809 [TBL] [Abstract][Full Text] [Related]
9. CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse. Velázquez RA; Kitto KF; Larson AA J Pharmacol Exp Ther; 1997 Jun; 281(3):1231-7. PubMed ID: 9190858 [TBL] [Abstract][Full Text] [Related]
10. Substance P induces expression of the corticotropin-releasing factor receptor 1 by activation of the neurokinin-1 receptor. Hamke M; Herpfer I; Lieb K; Wandelt C; Fiebich BL Brain Res; 2006 Aug; 1102(1):135-44. PubMed ID: 16806114 [TBL] [Abstract][Full Text] [Related]
11. Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes. Koon HW; Zhao D; Na X; Moyer MP; Pothoulakis C J Biol Chem; 2004 Oct; 279(44):45519-27. PubMed ID: 15319441 [TBL] [Abstract][Full Text] [Related]
12. alpha1-Adrenergic receptor stimulation of mitogenesis in human vascular smooth muscle cells: role of tyrosine protein kinases and calcium in activation of mitogen-activated protein kinase. Hu ZW; Shi XY; Lin RZ; Chen J; Hoffman BB J Pharmacol Exp Ther; 1999 Jul; 290(1):28-37. PubMed ID: 10381756 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 secretion from human astrocytoma cells induced by substance P. Gitter BD; Regoli D; Howbert JJ; Glasebrook AL; Waters DC J Neuroimmunol; 1994 Apr; 51(1):101-8. PubMed ID: 7512575 [TBL] [Abstract][Full Text] [Related]
15. Substance P receptor in U373 MG human astrocytoma cells activates mitogen-activated protein kinases ERK1/2 through Src. Yamaguchi K; Kugimiya T; Miyazaki T Brain Tumor Pathol; 2005; 22(1):1-8. PubMed ID: 18095097 [TBL] [Abstract][Full Text] [Related]
16. MEK1 is required for PDGF-induced ERK activation and DNA synthesis in tracheal myocytes. Karpova AY; Abe MK; Li J; Liu PT; Rhee JM; Kuo WL; Hershenson MB Am J Physiol; 1997 Mar; 272(3 Pt 1):L558-65. PubMed ID: 9124614 [TBL] [Abstract][Full Text] [Related]
17. Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells. Murakami-Mori K; Mori S; Bonavida B; Nakamura S J Immunol; 1999 Mar; 162(6):3672-9. PubMed ID: 10092829 [TBL] [Abstract][Full Text] [Related]
18. The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisst. Lowe JA; Drozda SE; Snider RM; Longo KP; Zorn SH; Morrone J; Jackson ER; McLean S; Bryce DK; Bordner J J Med Chem; 1992 Jul; 35(14):2591-600. PubMed ID: 1378901 [TBL] [Abstract][Full Text] [Related]
19. P2Y(2) receptor-mediated proliferation of C(6) glioma cells via activation of Ras/Raf/MEK/MAPK pathway. Tu MT; Luo SF; Wang CC; Chien CS; Chiu CT; Lin CC; Yang CM Br J Pharmacol; 2000 Apr; 129(7):1481-9. PubMed ID: 10742305 [TBL] [Abstract][Full Text] [Related]
20. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade. Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]